Tag:
Restructure
Latest Headlines
Latest Headlines
Emerging Drug Developer: Hollis-Eden
Emerging Drug Developer: Hollis-Eden For years, Hollis-Eden held out high hopes for Neumune, an experimental therapy for acute
THE LIBRARY: WEBINAR
Getting the most PoC data in Phase I cancer studies
The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!
EVENTS
- MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
- Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe
- What's your BIO?June 18-21, 2012 — Boston, MA
Press Releases
- T cells 'hunt' parasites like animal predators seek prey, study shows
- UC San Diego Researchers Receive New CIRM Funding
- Same gene that stunts infants' growth also makes them grow too big
- Chronic Pain Is Relieved by Cell Transplantation in Lab Study
- Drug-vaccine combo better for breast cancer
- More Press Releases
Featured Jobs
-
Aseptic Operations Manager
DPT Labs - Lakewood, NJ -
Director, Quality
Sucampo Pharmaceuticals - Washington, DC -
Food Development Scientist Job
Yoh - Park Ridge, NJ, USA -
Scientist II Job
Yoh - Niskayuna, NY, USA -
Analytical Scientist Job
Yoh - Durham, NC, USA
